Richard A. Barasch - 17 Jun 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Reporting relationship: Director
Issuer ticker: TOI
Reported as of: 17 Jun 2025
Net transaction value: -$13.82
SEC form: 4
Accepted by SEC: 24 Jun 2025, 19:17:42 UTC
Prior SEC filing: 28 Mar 2025
Next SEC filing: 28 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch

Key filing fact

Richard A. Barasch filed Form 4 for Oncology Institute, Inc. (TOI) on 24 Jun 2025.

Key facts

This page summarizes Richard A. Barasch's Form 4 filing for Oncology Institute, Inc. (TOI).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jun 2025, 19:17.

Change

Previous filing in this sequence was filed on 28 Mar 2025.
Current net transaction value: -$13.82.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001076341 Primary reporting owner

BARASCH RICHARD A

Relationship: Director
Address: C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS
Signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch
Signature date: 24 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TOI transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value: $813,710
Shares: +679,224
Change %: +27%
Price: $1.20
Shares after: 3,234,765
Date: 17 Jun 2025
Ownership: By LLC
Footnotes: F2, F4

TOI transaction

Common Stock

Tax liability

Transaction value: $813,724
Shares: -311,128
Change %: -9.6%
Price: $2.62
Shares after: 2,923,637
Date: 17 Jun 2025
Ownership: By LLC
Footnotes: F1, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TOI transaction Derivative

Common Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value: $0
Shares: -679,224
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Jun 2025
Ownership: By LLC
Underlying class: Common Stock
Underlying amount: 679,224
Exercise price: $1.20
Footnotes: F2, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the net exercise of a Common Stock Purchase Warrant ("Common Warrant") to purchase shares of common stock. The Common Warrant refers to such net exercise transaction as a "Cashless Exercise." In connection with the Cashless Exercise, the Issuer and RAB Ventures (DFP) LLC entered into a Waiver Agreement, pursuant to which the Issuer agreed to waive the Common Warrant provision restricting Cashless Exercises to circumstances where the resale of the underlying shares of common stock is not covered by an effective registration statement under the Securities Act of 1933, as amended.

Footnote F2

The exercise of the Common Warrant by RAB Ventures (DFP) LLC is exempt pursuant to Rule 16b-6.

Footnote F3

RAB Ventures (DFP) LLC received 368,096 shares of common stock on a net exercise of the Common Warrant to purchase 679,224 shares of common stock. The Issuer withheld 311,128 shares of common stock underlying the Common Warrant for payment of the exercise price, using the fair market value of the common stock on the date of exercise, June 17, 2025, of $2.6154. The fair market value of the common stock was determined based on the average of the volume weighted average price on each of the five (5) consecutive trading days ending immediately prior to the date of exercise, pursuant to the terms of the Common Warrant.

Footnote F4

Securities are owned by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein.